How to Trade BOT (RoboStrategy) on Hyperliquid

What RoboStrategy Actually Owns

RoboStrategy, Inc. is a non-diversified, closed-end management investment company that began trading on the NASDAQ under the ticker BOT on May 11, 2026. It bills itself as the first public closed-end fund built specifically to give ordinary investors exposure to private, pre-IPO robotics and physical-AI companies — the kind of cap table that is normally walled off to venture funds.

The holdings are concentrated and recognizable. As of its June 22 portfolio mark, the top positions were Figure AI (~$37.3M, ~19.4% of assets), Dyna (~$37.2M), Dexmate (~$25.4M), and Apptronik, with smaller stakes in Standard Bots, Path Robotics, and roughly a dozen other names spanning humanoids, industrial arms, medical robotics, and defense drones. Total net assets sat at about $191.6 million. The thing to internalize: this single ticker resolves to a basket of illiquid private equity, and that fact drives everything below.

The MicroStrategy Playbook, Applied to Robots

BOT is less a fund pitch than a financing-engine pitch. CEO Andrew Kang — co-founder, Mechanism Capital founder, and a crypto investor known for early DeFi bets — has been explicit that RoboStrategy is the "MicroStrategy of robotics." His own framing: roughly 97% of Strategy's per-share gains came from issuing stock at a premium to net asset value and recycling the proceeds, not from the underlying asset compounding. RoboStrategy is trying to run that exact loop on robotics equity.

The machinery is already turning. The fund has a $2 billion committed equity facility from Roth Principal Investments and has been raising in tranches — about $36.5 million in late June at a $29.65 weighted-average price, on top of an earlier ~$28.9 million round. Each raise above NAV is accretive and lifts book value per share. As long as the premium holds, the flywheel funds itself; if the premium breaks, the same mechanism works in reverse.

The Premium Is the Whole Story

Here is the number that should anchor your thinking: BOT trades around $32.07, while the fund's stated NAV per share was $8.92 as of June 22, 2026. You are paying roughly 3.6x the accounting value of the underlying portfolio. That premium *is* the trade — it is the engine that makes the issuance strategy accretive, and it is the single biggest risk to anyone holding the equity.

Closed-end funds routinely swing between premiums and discounts that have little to do with portfolio performance, and this one starts from an extreme premium. Layer on the fact that the underlying assets are private and illiquid — NAV is a periodic estimate of hard-to-value pre-IPO stakes, not a live mark — and you get an instrument whose price can move on sentiment, narrative, and float dynamics far more than on any Figure AI or Apptronik headline. Treat the premium as a sentiment gauge, not a floor.

The HIP-3 Perpetual

On Hyperliquid, BOT is listed as a HIP-3 perpetual future, meaning you trade a contract that tracks the BOT *share price* — premium and all — with up to 10x leverage, margined and settled in crypto. You never hold RoboStrategy stock, never carry a NAV claim, and never touch the restricted-share registration mechanics that govern the private placements. It is purely synthetic, directional exposure to the equity's mark.

Two things to keep front of mind. First, you are leveraging an instrument that already trades at a ~3.6x premium to book — the perp stacks leverage on top of an asset whose volatility is structurally high, so funding and liquidation risk are amplified. Second, HIP-3 liquidity in this name is still thin: 24h perp volume was around $1.4 million, so slippage and funding can be jumpy relative to a deep, mature market. Size accordingly and respect that this is a niche, premium-driven name wrapped in a leveraged contract.